Sep. 5 at 10:21 AM
$GERN I would like Geron to speak more on their developing patent for subcutaneous injections, which is very important, as it means convenience, and also on how cytopenias are actually proof of Rytelo's effectiveness. Hematologists would understand such things, particularly once they're educated on them, but Wall Street is always far behind, particularly if the science takes a bit of work to understand.
